Charles River Laboratories International, Inc.

Charles River Laboratories Beats on EPS, Stock Down 3.67%

Charles River Laboratories reported an EPS of $0.76, which was slightly above expectations. However, the stock fell by 3.67% following the earnings report, indicating that investors may have had concerns despite the earnings beat. The lack of additional information from the earnings call may have contributed to the negative stock reaction.